Understanding Scope of Schizophrenia in the United States
Schizophrenia is a widely misunderstood brain disorder that affects one percent of the population in the United States.
While the disorder affects individual all over the world and in all ethnic groups, and it affects males and females equally, with early onset becoming more common in males.
Support needs for those with Schizophrenia vary, but many manage the disorder with medications, community supports, and assisted living. Annual costs for the support of the Schizophrenia community range from $94 million to $104 billion.
Defining Schizophrenia and its Symptoms
Schizophrenia is a brain disorder that affects how a person thinks, feels or behaves. While symptoms of the disorder manifest themselves differently across individuals, common experiences include delusions, hallucinations, trouble with thinking and concentration, and lack of motivation.
Symptoms of schizophrenia fall into a few main categories including:
Positive symptoms describe behaviors not generally seen in healthy people, and are characterized by hearing voices, paranoid or exaggerated delusions or the general sense that the individual has lost touch with reality.
Negative symptoms represent a more withdrawn approach or a “flat” effect, with reduced participation in activities and reduced speech.
Cognitive symptoms refer to issues of focus, attention, and memory that can be more subtle than others.
Other symptoms include disorganization, or trouble with logical thinking or acting out in ways people would deem bizarre.
Common routes of treatment include antipsychotic pharmaceuticals as well as other psycho-social therapies that focus on developing learning and coping skills with this complicated brain disorder.
Medical Marijuana and Schizophrenia
The discourse on cannabis and Schizophrenia hasn’t been as prominent as other examinations into cannabis and medical issues, but early indicators of the effectiveness of cannabidiol (CBD) show promise.
This decade has had researchers in both the UK, Australia and other prominent countries investigate the effectiveness of CBD on the cognitive symptoms of brain disorders like Schizophrenia. With our advocacy, America’s body of research on CBD and Schizophrenia will catch up and create change.
A study in the United Kingdom in 2015 examined 88 patients with Schizophrenia, where half the participants used CBD while the others were administered a placebo. It was observed that there was a considerable cognitive improvement in this taking CBD.
A literature review conducted at the University of Wollongong observed a series of studies looking at neurological disorders that have similar patterns to Schizophrenia. While the review ultimately calls for more research into CBD for Schizophrenia, the conclusions show a positive correlation between CBD and the improvement of cognitive function.
This is particularly celebrated, as the antipsychotic medications often fail to treat the cognitive symptoms experienced with those with Schizophrenia.
It is noted that the effectiveness of CBD on Schizophrenia lies in its accompaniment in prescribed medications and under the supervision of a doctor. At this point, research on THC and Schizophrenia is not fully developed.
Are You Ready to Explore Medical Marijuana for Schizophrenia?
MyCannX is dedicated to being your resource and your connector for a loved one or your medical needs, available medical cannabis doctors, and your local dispensary. It starts with a discussion with a qualified doctor who is familiar with Schizophrenia, your treatment and the current research on medical marijuana and Schizophrenia.
Let us be your guide and help us advocate for more understanding on medical marijuana and its possibility in the lives of those with Schizophrenia. Connect with MyCannX to get your cannabis card and begin your journey towards finding out how CBD can help your cognition through often complicated brain disorder of Schizophrenia.